Abstract

10097Background: We sought to determine the safety and activity of IP bev for recurrent malignant ascites requiring repeated paracenteses, a major problem for women with CR-EOC. Methods: Eligible w...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Timing of intervention and complications of tunneled peritoneal catheter placement for recurrent malignant ascites in ovarian cancer patients
Kevin Shrestha ... Michael Straughn
Gynecologic oncology | VOL. 162
Kevin Shrestha, et. al.Kevin Shrestha ... Michael Straughn
01 Aug 2021
The FACIT-AI, a new tool for assessing symptoms associated with malignant ascites
David Cella ... Michael V Seiden
Gynecologic oncology | VOL. 128
David Cella, et. al.David Cella ... Michael V Seiden
15 Nov 2012
Central Venous Catheter as Peritoneal Indwelling Catheter for the Management of Recurrent Malignant Ascites: A Case Series.
Brajesh Kumar Ratre ... Sushma Bhatnagar
Indian Journal of Palliative Care | VOL. 25
Brajesh Kumar Ratre, et. al.Brajesh Kumar Ratre ... Sushma Bhatnagar
01 Jan 2019
Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study
Walter H Gotlieb ... Chanchal Goswami
Lancet Oncology | VOL. 13
Walter H Gotlieb, et. al.Walter H Gotlieb ... Chanchal Goswami
20 Dec 2011
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Leptomeningeal Metastasis in the Era of CNS-Penetrant Tyrosine Kinase Inhibitor Therapy.
Mark Y Jeng ... Helena A Yu
Journal of Clinical Oncology | VOL. 42
Mark Y Jeng, et. al.Mark Y Jeng ... Helena A Yu
10 Aug 2024
Management of Locally Advanced Rectal Cancer: ASCO Guideline.
Aaron J Scott ... Sepideh Gholami
Journal of Clinical Oncology | VOL. -
Aaron J Scott, et. al.Aaron J Scott ... Sepideh Gholami
08 Aug 2024
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201.
Jordan R Hansford ... Eric Bouffet
Journal of Clinical Oncology | VOL. -
Jordan R Hansford, et. al.Jordan R Hansford ... Eric Bouffet
07 Aug 2024
Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials.
Rik J Verheijden ... Karijn P M Suijkerbuijk
Journal of Clinical Oncology | VOL. -
Rik J Verheijden, et. al.Rik J Verheijden ... Karijn P M Suijkerbuijk
07 Aug 2024
View more papers